Joshua Foukas insider trades: Usana Health Sciences (USNA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Joshua reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 7, 2026 | USNA | ↓ Sell | 3,791 | $19.82 | $75K | Direct | May 8, 2026 (1d) |
| Mar 12, 2025 | USNA | ↓ Sell | 5,732 | $32.54 | $187K | Direct | Mar 13, 2025 (1d) |
| Feb 29, 2024 | USNA | ↓ Sell | 4,847 | $47.91 | $232K | Direct | Mar 4, 2024 (4d) |
| Feb 16, 2023 | USNA | ↓ Sell | 3,771 | $61.01 | $230K | Direct | Feb 17, 2023 (1d) |
| Aug 16, 2022 | USNA | ↓ Sell | 248 | $72.04 | $18K | Direct | Aug 17, 2022 (1d) |
| Mar 2, 2022 | USNA | ↓ Sell | 3,303 | $89.93 | $297K | Direct | Mar 4, 2022 (2d) |
| Oct 28, 2021 | USNA | ↓ Sell | 181 | $95.17 | $17K | Direct | Oct 29, 2021 (1d) |
| Aug 5, 2021 | USNA | ↓ Sell | 249 | $97.07 | $24K | Direct | Aug 9, 2021 (4d) |
| Feb 11, 2021 | USNA | ↓ Sell | 2,906 | $95.02 | $276K | Direct | Feb 16, 2021 (5d) |
| Oct 26, 2020 | USNA | ↓ Sell | 197 | $84.06 | $17K | Direct | Oct 27, 2020 (1d) |
| Aug 20, 2020 | USNA | ↓ Sell | 270 | $83.15 | $22K | Direct | Aug 21, 2020 (1d) |
| Apr 23, 2020 | USNA | ↓ Sell | 1,966 | $82.49 | $162K | Direct | Apr 27, 2020 (4d) |
| Feb 6, 2020 | USNA | ↓ Sell | 1,567 | $79.00 | $124K | Direct | Feb 10, 2020 (4d) |
| Oct 28, 2019 | USNA | ↓ Sell | 1,115 | $74.53 | $83K | Direct | Oct 30, 2019 (2d) |
| Oct 29, 2018 | USNA | ↓ Sell | 291 | $111.34 | $32K | Direct | Oct 31, 2018 (2d) |
| Sep 12, 2018 | USNA | ↓ Sell | 306 | $129.27 | $40K | Direct | Sep 14, 2018 (2d) |
| Sep 6, 2018 | USNA | ↓ Sell | 6,531 | $125.79 | $822K | Direct | Sep 6, 2018 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other USNA insiders
Open-market trades in the last 12 months
About Joshua Foukas's insider trades
Joshua Foukas is Chief Legal Officer at Usana Health Sciences (USNA). Since Sep 6, 2018, Joshua has reported no open-market purchases and 17 sales worth $2.7M on SEC Form 4. In the last 12 months: 1 sale ($75K).
Their filings also include option exercises (25 filings), shares withheld for taxes (24 filings), grants and awards (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every USNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.